Skip to main content
. Author manuscript; available in PMC: 2016 Nov 8.
Published in final edited form as: Int J Neuropsychopharmacol. 2012 Jul 25;16(2):445–458. doi: 10.1017/S1461145712000661

Table 2.

Potencies for inhibiting D2, D3 and D4 receptor function by buspirone and its metabolites

D2
IC50±S.E.M. (n)
D3
IC50±S.E.M. (n)
D4
IC50±S.E.M. (n)
Buspirone 0.67±0.12 (7) 0.44±0.18 (7) 0.35±0.06 (6)
5-OH Buspirone 2.6±1.3 (4) 0.93±0.46 (4) 1.4±0.82 (3)
6-OH Buspirone 3.1±1.8 (4) 4.9±2.8 (3) 0.85±0.49 (3)
1-PP >10 >10 >10

Functional assays were performed as described in Figs. 2 and 3.

Values are shown as μM.